APA (7th ed.) Citation

Blank, A., Fürle, K., Jäschke, A., Mikus, G., Lehmann, M., Hüsing, J., . . . Bujard, H. (2020). Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial. npj vaccines, 5, . https://doi.org/10.1038/s41541-020-0160-2

Chicago Style (17th ed.) Citation

Blank, Antje, et al. "Immunization with Full-length Plasmodium Falciparum Merozoite Surface Protein 1 Is Safe and Elicits Functional Cytophilic Antibodies in a Randomized First-in-human Trial." Npj Vaccines 5 (2020). https://doi.org/10.1038/s41541-020-0160-2.

MLA (9th ed.) Citation

Blank, Antje, et al. "Immunization with Full-length Plasmodium Falciparum Merozoite Surface Protein 1 Is Safe and Elicits Functional Cytophilic Antibodies in a Randomized First-in-human Trial." Npj Vaccines, vol. 5, 2020, https://doi.org/10.1038/s41541-020-0160-2.